Hologic to obtain $600 million term loan for acquisition of Third Wave

By Paul A. Harris

St. Louis, June 9 - Hologic, Inc. plans to obtain a new $600 million term loan as funding for its acquisition of Third Wave Technologies, Inc., according to a Monday press release.

Goldman Sachs & Co. is leading the deal.

Hologic is acquiring Third Wave Technologies for $11.25 per share in a transaction valued at about $580 million.

The new bank loan will have terms substantially consistent with the company's existing credit facility, according to the press release.

Third Wave Technologies is a Madison, Wis., developer of molecular diagnostic reagents for DNA and RNA analysis applications relating to conditions which include cystic fibrosis and hepatitis.

Hologic is a Bedford, Mass.-based developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products for the health care needs of women.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.